Rana Ghosh, PhD, second from left, of the University of Texas, Austin, is one of thousands of promising scientists whose careers have been advanced by PhRMA Foundation support.
Learn how YOUR project can be funded.
Value Assessment Initiative
The PhRMA Foundation’s Value Assessment Initiative advances high-quality care in the U.S., while avoiding low value or inefficient care. The initiative funds new research and innovative efforts to assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency.
The Awards
With a wide range of Pre- and Post-Doctoral Fellowships and Research Starter Grants, the Foundation offers a myriad of opportunities to advance your career. Learn more about the awards.
Featured Scientist
Julie Lade, PhD, received a PhRMA Foundation Pre-Doctoral Fellowship in Pharmacology/Toxicology in 2015. She is currently a staff scientist at Amgen, where she works in the Pharmacokinetics/Drug Metabolism Department. Julie was recognized by the Foundation in 2015 for her work on the effects of antiretrovirals for the treatment of human immunodeficiency virus (HIV) infection. At Amgen, Dr. Lade is striving to serve as a role model for other women in science. Read more…
Announcements
Utilize our site for updates and announcements or follow PhRMA Foundation on twitter @PhRMAFoundation
PhRMA Foundation Surpasses $2.8 Million in Funding for Leaders in Value Assessment
The PhRMA Foundation has announced a new cycle of awards to support transformative strategies that better assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency in health care. More than $2.8 million has been provided to date to establish four national value-assessment Centers of Excellence and support the work of several researchers focused on value-based health care. Learn more about the awards and how to apply for 2019 or 2020 funding.
PhRMA Alumna Norelle Wildburger: Taking Aim at Alzheimer’s
Norelle Wildburger, PhD, of Washington University in St. Louis is using her PhRMA Foundation funding to better understand the development process of plaque and tangles in Alzheimer’s patients. She and her team have launched a project, working with advanced Alzheimer’s patients who are studied during hospice and whose brains are donated to science following death, that will help shed new light on the timing of Alzheimer’s treatments. A short video video explains and highlights Dr. Wildburger’s work. Watch the video here. Dr. Wildburger was the recipient of a PhRMA Foundation Post-Doctoral Fellowship in Translational Medicine and Therapeutics in 2017.
Learn More About the Foundation in our 2017 Annual Report
Over the last year, the PhRMA Foundation provided more than $3.2 million in funding to dozens of the nation’s leading young researchers, while supporting important new initiatives in areas such as Value Assessment in health care. View a copy of the the annual report here.
